x
Turning science into breakthroughs
Accelerating the preclinical development of new drugs for improved quality of life and cures for disease
On December 18, 2019, Duke University and Deerfield Management announced the launch of Four Points Innovation, a strategic partnership focused on supporting and accelerating the translation of research into new therapies to treat and cure society’s most formidable healthcare challenges.
Through this partnership, Deerfield will fund Four Points Innovation with up to $130 million and provide development expertise in support of Duke’s innovative drug research across a span of high-need therapeutic areas.
Deerfield is a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.
Duke is a private research university in Durham, North Carolina with nearly 16,000 undergraduate, graduate, and professional students and a world-class faculty helping to expand the frontiers of knowledge. The Duke School of Medicine is one of the nation’s leading centers for medical education, clinical care and biomedical research.
Proposal Submissions
To learn more about project sourcing and evaluation, please reach out to Four Points Scientific Collaboration Director, C. Tony Liu, at tony.liu@duke.edu.
Updates from Cure.
Cure. is a Deerfield affiliate and premier healthcare innovation ecosystem headquartered in New York City, with a mission to accelerate cures by helping health innovators develop groundbreaking products and services from concept to commercialization.
Content is generated and provided by third parties, including Cure, an affiliate of Four Points and Deerfield, and has not been reviewed or approved by Four Points or Deerfield.